For clinical photovaporization of cutaneous lesions, practitioners should prioritize controlled, layer-by-layer ablation over maximum power or depth. A commonly described protocol for superficial premalignant epithelial lesions uses a defocused CO2 beam, approximately 15–20 W, with a spot size near 2 mm, vaporizing to roughly 2 mm depth and extending treatment up to 1 cm beyond the visible lesion margin when clinically appropriate. These parameters are starting points, not universal prescriptions: tissue type, lesion thickness, location, laser model, beam mode, and the need to preserve function must determine the final settings.
The central principle is visual and incremental control: use a defocused beam, remove debris between passes, treat the lesion and clinically indicated margins, and stop when the intended tissue endpoint is reached without unnecessary thermal injury.
Establish the Treatment Objective Before Ablation
Confirm That Vaporization Is Appropriate
CO2 laser vaporization can provide favorable functional and cosmetic results for selected superficial lesions, including actinic cheilitis, leukoplakia, localized premalignant epithelial lesions, warts, papillomas, and other exophytic lesions.
Premalignant or suspicious lesions should be clinically assessed and biopsied when diagnosis, invasion, or margin status is uncertain. Photovaporization destroys tissue, so it cannot provide a specimen for later histopathologic evaluation.
Define the Lesion and Its Margins
Visible borders may underestimate the extent of epithelial abnormality. For selected premalignant lesions, the described protocol extends vaporization horizontally by as much as 1 cm beyond the visible border, provided that anatomy and tissue preservation permit it.
This margin should be individualized rather than applied mechanically. The acceptable margin on the lip, eyelid, nose, or other functionally sensitive site may differ from that on less critical skin.
Select Beam Configuration and Power
Use a Defocused Beam for Vaporization
A defocused beam distributes energy over a broader area and supports relatively homogeneous vaporization of superficial tissue. It is generally more appropriate for ablation than a focused beam, which is primarily intended for cutting.
A prefocused or insufficiently defocused beam can concentrate thermal energy at depth and increase the risk of scarring or injury to adjacent structures.
Use Approximately 15–20 W as a Reference Range
For the lesion types described in the primary protocol, a defocused beam with approximately 15–20 W and a 2 mm spot is a reasonable reference configuration.
Published operating descriptions vary substantially, including lower settings for thin lesions and higher continuous-wave settings for small lesions. Those figures should not be combined into a single universal protocol because laser power depends on spot size, mode, tissue hydration, handpiece distance, movement speed, and the specific device.
Match Mode to Lesion Characteristics
Continuous-wave operation may be useful for larger or thicker lesions requiring steady layer removal. Superpulse or pulsed operation may be appropriate for small or thin lesions when the system and operator are experienced with that mode.
The relevant variable is not power alone. Power density and tissue dwell time determine the rate of heating, carbonization, and depth of thermal injury.
Control Depth Precisely
Treat in Sequential Tissue Layers
Layer-by-layer vaporization provides the clearest depth control. After each pass, gently remove vaporized tissue and carbonized debris with an appropriate moistened swab or saline, then reassess the surface before continuing.
This exposes hydrated tissue, improves visualization, and reduces the chance that char will absorb excessive energy and transmit heat into deeper tissue.
Use Approximately 2 mm as the Described Target
For the superficial premalignant lesions addressed in the primary reference, the intended vaporization depth is approximately 2 mm.
That depth should be treated as a clinical target rather than a fixed setting. The operator should account for lesion thickness, epithelial anatomy, location, and the possibility that apparent surface clearance may not equal complete removal of abnormal tissue.
Avoid Automatically Ablating to Fat
Some procedural descriptions identify visibly fluid superficial fat as an endpoint for complete destruction of small lesions. This may be relevant for selected benign or exophytic lesions, but it should not be treated as a universal rule for every cutaneous or mucosal lesion.
Ablating to the fatty layer can increase pain, delayed healing, scarring, contour change, and injury to nearby structures. The endpoint must be tied to the diagnosis and treatment objective, with tissue conservation favored where deeper destruction is not necessary.
Use Controlled Handpiece Movement
Maintain a Nearly Perpendicular Orientation
Holding the handpiece close to perpendicular to the treatment surface helps distribute energy predictably and reduces the risk of undermining wound edges or unintentionally removing adjacent normal dermis.
This is particularly important when treating small lesions and when the wound margins must remain structurally supported.
Keep the Beam Moving
Use slow, uniform circular, airbrush-like, or pirouetting movements rather than holding the beam continuously over one point.
Continuous movement reduces peripheral charring and localized overheating. Movement speed should be adjusted so that each pass removes the intended layer without producing excessive carbonization.
Keep the Field Clean and Appropriately Moist
Carbonized debris is a strong thermal absorber. If it remains on the surface, subsequent irradiation can produce disproportionate heating and obscure the treatment endpoint.
Regularly clearing debris and maintaining suitable tissue moisture support more controlled ablation. Cleansing between passes should follow the facility's established protocol and the device manufacturer's instructions.
Recognize the Clinical Endpoint
Confirm Removal of the Target Tissue
The operator should reassess the entire lesion, including its base and planned margins, after each pass.
The endpoint is not simply a change in surface color. It is the visually confirmed removal of the intended abnormal tissue while avoiding unnecessary injury to deeper or surrounding structures.
Balance Clearance Against Tissue Preservation
More vaporization is not automatically better. Excessive depth may increase scarring and healing time without improving treatment effectiveness.
On cosmetically or functionally important sites, the endpoint should reflect the smallest treatment volume that adequately addresses the confirmed lesion and its clinically relevant margins.
Protect the Patient and Clinical Team
Use Standard CO2 Laser Safety Measures
CO2 lasers at 10,600 nm can cause significant ocular and tissue injury. Appropriate wavelength-specific eye protection, controlled access, warning signage, nonreflective instruments where applicable, and protection of surrounding structures are essential.
Local anesthesia may be required for patient comfort, especially when treating larger areas or sensitive sites.
Control Surgical Smoke
Vaporization generates surgical plume that may contain hazardous particulate and biologic material. A dedicated smoke evacuator or fume-extraction system should be positioned close to the treatment site and used throughout ablation.
General room ventilation alone is not an adequate substitute for source capture.
Use Magnification When It Improves Precision
For facial or anatomically delicate lesions, an operating microscope or other suitable magnification can improve visualization and support precise, layer-by-layer treatment.
Magnification does not replace clinical judgment or margin assessment, but it can make subtle residual tissue and treatment endpoints easier to evaluate.
Manage Healing and Follow-Up
Provide a Simple Wound-Care Plan
Post-procedure care commonly includes a topical ointment and a non-adherent dressing, followed by gentle daily cleansing according to local protocol.
The exact product and dressing plan should account for allergy history, infection risk, anatomic location, and institutional practice.
Set Expectations for Re-Epithelialization
Re-epithelialization may occur over approximately 2–3 weeks, while erythema can persist longer and gradually resolve over several weeks to months.
Patients should be informed about the possibility of localized scarring, pigmentary change, delayed healing, infection, pain, and lesion recurrence.
Arrange Surveillance
Follow-up is particularly important for premalignant lesions, lesions treated without a specimen, and sites where recurrence may be difficult to recognize.
Persistent abnormality, recurrent keratosis, induration, ulceration, or a changing lesion warrants reassessment and possible biopsy rather than repeated empiric vaporization.
Understanding the Trade-offs
Higher Power Does Not Guarantee Better Clearance
Increasing power can accelerate tissue removal, but it also increases the risk of carbonization and uncontrolled thermal spread if the beam is held too long or the surface is not cleared.
Power must therefore be interpreted together with spot size, mode, movement, distance, and tissue response.
Deeper Ablation Can Increase Morbidity
Treating to a deeper endpoint may reduce residual lesion tissue in some circumstances, but it can also increase scarring, contour change, pain, and healing time.
The appropriate depth is diagnosis- and site-specific. A protocol designed for a small exophytic lesion should not automatically be transferred to mucosa, thin facial skin, or a premalignant field.
Cosmetic Results Are Not the Only Outcome
CO2 vaporization can reduce the morbidity associated with aggressive excision, but favorable cosmetic results do not eliminate oncologic or diagnostic responsibilities.
The clinician must still establish an appropriate diagnosis, select suitable margins, document the treated area, and monitor for recurrence.
Making the Right Choice for Your Goal
Use the following principles to adapt the procedure to the clinical objective:
- If your primary focus is controlled superficial vaporization: Begin with a defocused beam, a roughly 2 mm spot, and the described 15–20 W reference range, then proceed in cleaned, incremental passes.
- If your primary focus is margin control for a premalignant lesion: Define the treatment field before ablation and consider extension beyond the visible border, up to approximately 1 cm when clinically justified and anatomically safe.
- If your primary focus is minimizing scarring: Avoid an automatically deep endpoint, prevent char accumulation, keep the beam moving, and stop once the intended tissue has been adequately cleared.
- If your primary focus is complete removal of a small exophytic lesion: Treat the lesion, base, and clinically relevant margins layer by layer, using the observed tissue endpoint rather than power alone.
- If your primary focus is procedural safety: Use wavelength-appropriate eye protection, smoke evacuation, controlled access, local anesthesia when needed, and structured follow-up.
The safest CO2 laser protocol is one that combines validated device settings with incremental visual depth control, anatomically appropriate margins, and disciplined post-treatment surveillance.
Summary Table:
| Parameter/Consideration | Recommended Approach | Key Points |
|---|---|---|
| Beam Focus | Defocused | Distributes energy evenly, reduces deep thermal injury |
| Power | 15–20 W reference | Adjust based on spot size, mode, tissue, and device |
| Spot Size | ~2 mm | Larger spot for broader vaporization |
| Depth | ~2 mm target | Incremental layers, avoid unnecessary deep ablation |
| Margins | Up to 1 cm beyond visible lesion | Individualize based on anatomy and lesion type |
| Handpiece Movement | Slow, uniform, nearly perpendicular | Prevents charring and overheating |
| Debris Removal | Between passes with moistened swab | Maintains visualization and controls thermal damage |
| Endpoint | Visual confirmation of tissue removal | Balance clearance with tissue preservation |
| Safety | Eye protection, smoke evacuation, controlled access | Essential to protect patient and staff |
Elevate your practice with BELIS's advanced CO2 fractional lasers, designed for precise, controlled photovaporization. Our systems offer customizable parameters and superior safety features, empowering you to achieve optimal clinical outcomes while minimizing downtime. Whether you're treating premalignant lesions or seeking versatile aesthetic solutions, our expertise supports your success. Contact us today to discover how BELIS can enhance your clinic's capabilities and patient satisfaction.
Related Products
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What is the rationale for a double-pass technique with fractional CO2 lasers? Maximize Deep Collagen Remodeling
- What role does fractional CO2 laser equipment play in the treatment of SUI? Non-Surgical Stress Urinary Incontinence Care
- What is the core function of the CO2 fractional laser system in the treatment of hypertrophic burn scars? Deep Insights
- What is the purpose of manually extracting large cysts before CO2 fractional laser? Optimize Eyelid Milia En Plaque Care
